Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
Sponsor: The University of Texas Health Science Center, Houston
Summary
The purpose of this study is to see how well pioglitazone, when used with cognitive behavioral therapy, works at helping people who have recently stopped using cocaine to continue to not use cocaine.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
61
Start Date
2021-08-23
Completion Date
2025-10-15
Last Updated
2026-09-21
Healthy Volunteers
No
Conditions
Interventions
Cognitive Behavioral Therapy (CBT)
All participants will receive evidence-based individual Cognitive Behavioral Therapy (CBT) shown to be an effective intervention for maintaining abstinence following detoxification. Trained masters-level licensed professional counselors will deliver CBT.
Pioglitazone
Pioglitazone capsules will start at 30 mg (Detox days 3 and 4) and increase to fixed dose of 45 mg for study weeks 1-12 and will also contain riboflavin.
Placebo
Placebo capsules will be filled with corn starch and riboflavin.
Locations (1)
UTHealth Center for Neurobehavioral Research on Addiction
Houston, Texas, United States